Complete List of Antineoplastic agent, androgen biosynthesis inhibitor Medicines
                
                
                
                    
                    
                        Brand: ABREMIA | 
                        Strength: 250 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone  
Adult dose: | 1000 mg (fou...
                    
                    
                 
                
                
                    
                    
                        Brand: CYPROST | 
                        Strength: 250 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone or prednisolone  
Adult dose...
                    
                    
                 
                
                
                    
                    
                        Brand: CYPROST | 
                        Strength: 500 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate canc...
                    
                    
                 
                
                
                    
                    
                        Brand: TEROPROS | 
                        Strength: 500 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC), often in combination with prednisone  
Adult dose: | 1000 ...
                    
                    
                 
                
                
                    
                    
                        Brand: ZYTIGA | 
                        Strength: 250 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for treatmen...
                    
                    
                 
                
                
                    
                    
                        Brand: ZYTIGA | 
                        Strength: 250 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for high-ris...
                    
                    
                 
                
                
                    
                    
                        Brand: ZYTIGA | 
                        Strength: 500 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for high-ris...
                    
                    
                 
                
                
                    
                    
                        Brand: ZYTIGA | 
                        Strength: 500 mg | 
                        Form: Tablets
                    
                    
                    
                        Class: | Antineoplastic agent, androgen biosynthesis inhibitor  
Use: | Treatment of metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone; also indicated for high-ris...